‘Trailer Park Boys’ Endorse Marijuana Brand For Medical Use Then For Recreational Use Soon?
TV’s “Trailer Park Boys,” Canada’s notorious doping figures will be brand endorsers for OrganiGram Holdings Inc., the New Brunswick marijuana producer. The group confirmed their choice saying that the Moncton company is now their exclusive Canadian cannabis producer as well as business partner and brand developer, additionally.
OrganiGram is a licensed producer of marijuana for medical uses. It aspired to even work with the “Trailer Park Boys” to develop particular branding and packaging for recreational users when that is legalized understandably within the five-year contract. It’s however expected soon.
They intended to solidify their relationship with the famous endorser as a strategy for the future project as soon as the legalization of marijuana for recreational use is approved in Canada, said Ray Gracewood, OrganiGram’s chief commercial officer. Sonic Entertainment Group president, Louis Thomas also feels that OrganiGram is a good partner judging from their first meeting.
The Marijuana producer prides itself into expressing their commitment being the source of world-class cannabis for the ever increasing market base, according to the OrganiGram website. Ray Gracewood that OrganiGram is closely monitoring how they could possibly increase their presence in the cannabis industry in Canada.
Sonic is the representative of TPB Productions Limited – which is Nova Scotia company operated by the three actors in the “Trailer Park Boys” thus owning its copyright in the said deal. The federal government of Canada is scheduled to bring out the marijuana legislation next spring. That should be followed by the committee report by the end this month.
OrganiGram as per Gracewood will always be dedicated to patients needed Marijuana for medical purposes but also need to do some strategies to potentially capture the recreational use market to be able to continue as the producer for world-class Marijuana, as published by the Huffington Post.
No comments:
Post a Comment